Five Prime Therapeutics Completes Phase 1 Safety Lead-In and Initiates Phase 3 Global Registrational Trial of Bemarituzumab
Bold Ventures Provides Update on Burchell Drilling Progress and Announces PDAC Participation at Booth #2610